scholarly article | Q13442814 |
P356 | DOI | 10.1089/107999002753536248 |
P698 | PubMed publication ID | 11911810 |
P2093 | author name string | Betty Lamothe | |
Bharat B Aggarwal | |||
P433 | issue | 2 | |
P921 | main subject | leukemia | Q29496 |
P304 | page(s) | 269-279 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | Journal of Interferon and Cytokine Research | Q15754749 |
P1476 | title | Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. | |
P478 | volume | 22 |
Q39392672 | AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules |
Q40388128 | Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO. |
Q43673692 | Analysis of TNF-related apoptosis-inducing ligand in vivo through bone marrow transduction and transplantation |
Q28176737 | Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy |
Q80362724 | CDK11(p58) protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway |
Q35198905 | Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications |
Q40431685 | Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells |
Q44319730 | Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation |
Q40518043 | Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). |
Q40553526 | Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. |
Q38997397 | Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene. |
Q40587921 | Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells. |
Q42176172 | Ethanolic extract of Thevetia peruviana flowers enhances TNF-α and TRAIL-induced apoptosis of human cervical cancer cells via intrinsic and extrinsic pathways |
Q37729281 | Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines |
Q30881749 | Localization of TRAIL/TRAILR in fetal pancreas |
Q40094198 | Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization. |
Q40846156 | Modulation of neutrophil apoptosis by antimicrobial peptides |
Q39594325 | NSP 5a3a: a potential novel cancer target in head and neck carcinoma |
Q34072314 | Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin |
Q35756929 | Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors |
Q24683245 | Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand |
Q33855963 | Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway |
Q39263297 | TRAIL-NP hybrids for cancer therapy: a review. |
Q36392814 | Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist |
Q34139621 | Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo. |
Search more.